• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives

    2022-06-29 01:46:54LieZhengYongYiJiXinLiWenShengLeiDuan
    World Journal of Gastroenterology 2022年23期

    Lie Zheng, Yong-Yi Ji, Xin-Li Wen, Sheng-Lei Duan

    Abstract With the development of microbiology and metabolomics, the relationship between the intestinal microbiome and intestinal diseases has been revealed. Fecal microbiota transplantation (FMT), as a new treatment method, can affect the course of many chronic diseases such as metabolic syndrome, malignant tumor,autoimmune disease and nervous system disease. Although the mechanism of action of FMT is now well understood, there is some controversy in metabolic diseases, so its clinical application may be limited. Microflora transplantation is recommended by clinical medical guidelines and consensus for the treatment of recurrent or refractory Clostridium difficile infection, and has been gradually promoted for the treatment of other intestinal and extraintestinal diseases.However, the initial results are varied, suggesting that the heterogeneity of the donor stools may affect the efficacy of FMT. The success of FMT depends on the microbial diversity and composition of donor feces. Therefore, clinical trials may fail due to the selection of ineffective donors, and not to faulty indication selection for FMT. A new understanding is that FMT not only improves insulin sensitivity,but may also alter the natural course of type 1 diabetes by modulating autoimmunity. In this review, we focus on the main mechanisms and deficiencies of FMT, and explore the optimal design of FMT research, especially in the field of cardiometabolic diseases.

    Key Words: Fecal microbiota transplantation; Metabolic diseases; Inflammatory bowel disease; Type 1 diabetes; Metabolic syndrome

    INTRODUCTION

    Most of the research on microorganisms is confined to infectious diseases and the role of microorganisms in human health is largely ignored. The average weight of these microorganisms is about 1.5 kg, equivalent to the weight of the liver. There are 1012-1014microorganisms, which is 10 times the number of the human body’s own cells, and they are mainly parasitic in the intestinal tract[1]. These symbiotic microorganisms include bacteria, viruses, archaea, fungi and, in some cases, protists,collectively known as the microbiome. The most important advantage of fecal microbiota transplantation (FMT) is the determination of cause and effect of disease through microbiology[2] .

    During the long process of human evolution, the intestinal flora has coevolved with its host, along with social development, changes in diet, lifestyle and environment. Intestinal symbiotic bacteria can regulate a variety of metabolic activities that cannot be carried out by the human body itself[3]. They can obtain energy by decomposing polysaccharides, proteins and fats in food that cannot be fully digested by the host, and produce a series of metabolites that affect the health of the host. In this process, the intestinal microecosystem is closely related to the host metabolic capacity[4].

    As early as 3000 years ago, cow dung was used in India to treat gastrointestinal diseases. As early as the Eastern Jin Dynasty (317-420 AD), a treatment similar to fecal bacterial transplantation, called“Huanglong Soup”, was described in Ge Hong’s “Urgent Prescription for Elbow Reserve”, which was used to treat food poisoning and diarrhea. In traditional Chinese medicine, it is recorded that huanglian and rhubarb, among others, have the curative effect of “quenching thirst” (ancient term for diabetes).Berberine, a monomer component from huanglian, has been recognized internationally for its effect on improving glucose and lipid metabolism earlier. During World War II, German soldiers in North Africa treated diarrhea with camel excrement[5]. At present, FMT is mainly used for the treatment of recurrentClostridium difficileinfection (CDI) in clinical practice, and many clinical trials have confirmed that FMT is a feasible treatment[6].

    At present, with the development of fast and accurate high-throughput sequencing technology and the improvement of bioinformatics technology methods, intestinal flora is closely related to metabolic syndrome (MS), type 1 diabetes (T1D) and type 2 diabetes (T2D), various cancers, and autoimmune diseases. Currently, it is believed that the FMT donor should be carefully selected and examined for infectious diseases[7]. However, due to the large difference in metabolism and diet of FMT donors, the effect of transplantation can be different. In this review, the mechanisms and deficiencies of FMT are discussed, and the optimal design of FMT is explored to maximize scientific research and clinical application methods.

    COMPOSITION AND METHOD OF FMT

    The main components of FMT are the gut flora of humans and other species. Humans have evolved to come into contact with a variety of bacteria, including those produced by food fermentation. The oral cavity is an important location of intestinal microbiota, which has an important effect on human health.Studies have shown that children who grow up on farms have a lower risk of asthma; a phenomenon that may be linked to changes in their gut microbiota[8]. In addition, babies born by cesarean section are at increased risk of developing autoimmune diseases, mainly because the initial microbes passed from the vagina to the baby at birth are replaced by skin microbes from the mother and surgical team members, which alter the baby’s gut microbes[9]. An infant’s gut microbiome can be reshaped in breast milk by adding small amounts of bacteria from the mother’s feces, creating a pattern that more closely resembles that of babies born vaginally[10].

    FMT has been processed into an odorless and tasteless preparation. In clinical practice, there are three methods of bacterial flora transplantation for patients willing to accept FMT: Upper, middle and lower digestive tract. The methods of transplanting upper digestive tract microflora mainly include oral microflora liquid and oral microflora capsule. The middle digestive tract approach includes a nasointestinal tube, endoscopic biopsy hole, percutaneous endoscopic gastrostomy and jejunal catheterization, endoscopic catheterization such as Transendoscopic enteral tubing (TET)[11]. The lower gastrointestinal pathway includes colonoscopy, colostomy, enema, and colonic pathway TET. Colonic pathway TET is not only used for microflora transplantation, but also for whole colon administration such as mesalazine, hormones and traditional Chinese medicine. As a new endoscopic technique, TET is an important supplement for interventional treatment of inflammatory bowel disease[12].

    FMT focuses on flora transplantation, but other components, such as phages, should not be ignored,which may be the reason for FMT’s effectiveness in the treatment of recurrent CDI. Therefore, phage research is important, and animal studies have shown that fecal virus transplantation also plays an important role. Analysis of the feces of adults on a classic British diet found that 25% of the 100 g/d excreted was made up of bacteria and 75% of fiber, protein, fat, bile acids and short-chain fatty acids(SCFAs). In most FMT, however, feces are simply mixed with salt water and filtered to remove insoluble substances[13]. Thus, the potential effects of FMT may be partly due to the combined effects of these compounds (Figure 1).

    AUTOLOGOUS FMT

    Most studies have focused on fecal transplants from healthy donors (known as FMT allografts).However, autologous fecal transplants have significant advantages[14], such as reducing the risk of infection and increasing the efficiency of transplantation, especially in the treatment of recurrent CDI by freezing their own feces. Autologous fecal transplants are effective in many diseases, but not in disorders caused by intestinal flora disorders, such as inflammatory bowel disease[15]. Studies have shown that disorder of intestinal flora can aggravate the disease, and intestinal inflammation can also affect the composition of intestinal flora[16]. Therefore, it is speculated that fecal biobanks may contain probiotics, which have changed the composition of intestinal flora before the relapse of the disease. This requires further confirmation of the value of probiotics in intestinal flora, but there is insufficient evidence to confirm the value of probiotics collected in clinical remission. Therefore, autologous FMT can improve clinical symptoms by regulating intestinal flora to promote metabolism[17].

    In conclusion, regulating the balance of intestinal flora is the primary goal of therapy. Autologous FMT through a duodenal tube or oral capsules can reshape the composition of small intestinal flora,which play an important role in the regulation of autoimmune diseases[18], mainly because the immune system response to antigenic stimuli occurs in the small intestine. It has also been suggested that autologous FMTviathe duodenal tube may be valuable in a new method of preserving β-cell function for T1D diagnosis that is more effective than healthy donor FMT[19].

    FMT AND METABOLIC DISEASES

    MS

    To date, the only reported study of FMT in the treatment of human MS was conducted by Witkowskiet al[20]. This study examined the effects of FMT on glucose and lipid metabolism in men with MS in a double-blind randomized controlled trial in nine patients receiving fecal bacteria transplants from lean healthy donors (allograft group) and nine other patients[21]. They received their own fecal bacteria as a control (autologous transplantation group)[22]. After 6 wk of FMT treatment, insulin sensitivity and fecal microbial diversity were significantly increased in the allograft group, while no significant changes were observed in the autograft group. It should be noted that there were individual differences in the efficacy of FMT[23], and Gagliardiet al[24] suggested that the differences might have been more due to different donors than recipients, since the two subjects receiving fecal bacteria from the same donor showed similar benefits[24]. In a randomized, double-blind, controlled trial of fecal bacteria transplantation in patients with MS it was found that insulin sensitivity and butyric acid-producing intestinal flora significantly improved in patients receiving fecal donation[25]. FMT strengthened the intestinal barrier function and effectively reduced endotoxemia in a nutritionally obese rat model. It is also concluded that FMT can regulate the lipid content of obese rats and reduce hepatic steatosis[26]. There are currently four clinical trials of FMT for MS registered with clinicaltrials.gov. We believe that the results of these clinical trials can provide us with a better understanding of the role of intestinal flora in human metabolic disorders[27].

    T1D

    Figure 1 Components that are transferred during fecal transplantation.

    There is a close relationship between intestinal flora and diabetes mellitus. Some studies have found that the decrease of butyrate- and lactate-producing bacteria is related to the autoimmunity of β cells[28]. In addition, it has been found that the intestinal flora of children with β-cell-related autoimmune diseases lacksBifidobacterium, and the bacteria producing butyrate and lactate are reduced while Bacteroidetes are increased[24]. Another study in Spain found similar changes in the gut flora of children with T1D, suggesting that structural changes in the gut flora may be associated with T1D[29]. A meta-genomic analysis of the intestinal flora in an included study found that, compared with the control group, patients with T1D had fewer butyrate-producing bacteria and mucin-degradingPrevotellaandAkkermansia, and had more lactate-producing bacteria, and bacteria-producing SCFA other than butyrate, such asBacteroidesandRiyanella[30].All of these suggest that gut bacteria may participate in the disorder of immune function in patients with T1D[31].

    Dietary fiber can be metabolized and fermented by intestinal bacteria into SCFAs, including acetic acid, propionic acid and butyric acid, which may also be involved in the pathogenesis of metabolic diseases[32]. The types and quantities of SCFAs are thought to vary with the composition of intestinal microbes. In addition to serving as an energy source for intestinal epithelial cells and liver (SCFAs are absorbed by the intestine and transported mainly through the portal vein), SCFAs are thought to have immunomodulatory effects by reducing intestinal permeability[33]. Lipopolysaccharides from intestinal translocation to the portal vein are thought to be involved in obesity-related mild inflammatory responses and insulin resistance in mice[34].

    SCFAs produce a small number of microorganisms in T1D, and the incidence of T1D is significantly reduced in nonobese diabetic mice treated withAkkermansiaor with a prebiotic diet supplemented with SCFAs[35]. It has been suggested that the restoration of intestinal flora balance through healthy donor FMT may further weaken autoimmune function and β-cell dysfunction[36]. A recent study showed that both healthy autologous and allogeneic FMT attenuates the decline of β-cell function, while donor FMT decreases at a slower rate[37]. Surprisingly, the decay rate of autologous FMT b cells was only 12 mo after three consecutive FMT treatments. Due to the significant changes in microbes from the mouth to the anus during autologous FMT[38], the immune system of the small intestine can be reshaped. Due to the lack of effective immunomodulators to treat T1D, a large number of clinical studies are needed to confirm this[39].

    T2D

    The association between intestinal flora and T2D was first reported by Chinese researchers led by The Shenzhen Huada Institute for Life Sciences and published in Nature in 2012[40]. This study found that the relative abundance of clostridium butyricum and its butyric acid-producing function in Chinese patients with T2D were significantly lower than those in the normal population, and lipopolysaccharide produced by conditional pathogenic Enterobacteriaceae species, hydrogen sulfide proinflammatory function and branched chain amino acid transport function levels were significantly higher than the general population[41]. These changes may be associated with impaired intestinal mucosal barrier function and increased levels of intestinal inflammation in T2D patients[42].

    A randomized controlled study showed that autologous FMT can maintain normal metabolism after diet-induced weight loss[43]. It has been observed that obese donor FMT can cause rapid weight gain,so there is a link between the intestinal microbiome, obesity and insulin resistance[44]. On the contrary,non-obese donor FMT can improve insulin resistance in obese patients with MS. Another study found that donor FMT had no effect on glucose metabolism and their diets were metabolically tested. Recent studies have shown that the use of single-dose capsule FMT improves lipid metabolism and insulin resistance, mainly through continuous supplementation of low-fermenter fiber[45]. Therefore, dietary composition may affect insulin resistance of FMT, or metabolites of donor FMT may affect the enteric-brain axis[46].

    NONALCOHOLIC FAATTY LIVER DISEASE

    The relationship between intestinal microflora and nonalcoholic faatty liver disease (NAFLD) is increasingly close, research suggests. Intestinal flora can affect the occurrence and development of NAFLD by changing the composition of intestinal flora, increasing serum endotoxin level and intestinal permeability, producing endogenous alcohol and changing choline metabolism[47]. Animal studies have shown that FMT can improve steatohepatitis in mice induced by high-fat diet, reduce the production of lipids and proinflammatory factors in the liver, regulate the balance of intestinal flora in mice, and increase the abundance of beneficial flora[48]. After FMT treatment, the cecal butyrate concentration and intestinal tight junction protein ZO-1 increased, and the toxin release decreased, thus reducing the inflammatory response[49].

    Increased intestinal permeability and metabolic endotoxin caused by changes in intestinal flora composition are involved in the progression of NAFLD in mice, and the severity of NAFLD in mice is increased when special flora are transferred to methionine- and choline-deficient diet, indicating that intestinal flora is involved in the progression of NAFLD[50]. The results of human studies also support the idea that changes in gut flora can contribute to fatty liver disease. Compared with normal subjects,NAFLD patients showed increased intestinal permeability, endotoxemia, increased numbers of g-Proteobacteria, and decreased numbers of Bacteroidetes[51].

    Fatty liver often occurs in obese patients. Long-term vegans have a lower risk of NAFLD, which may be related to changes in gut flora. It is suggested that FMT treatment of long-term vegan feces can improve liver inflammation score[52]. Despite the small sample size, this study still found that the inflammatory necrotic tissue score and inflammatory gene expression were reduced after transplantation of vegan fecal flora, which may be an important indicator for predicting the progression of NAFLD to cirrhosis[53]. At the same time, an FMT study in NAFLD patients showed that healthy donor FMT reduced intestinal permeability, which is an important feature that distinguishes NAFLD from other diseases[48]. This study found that magnetic resonance imaging could not make a definitive diagnosis of hepatic adipose degeneration, which must be assessed using gold standard liver histological examination[54].

    PITFALLS

    Mode of delivery

    Since innate and adaptive immune cell reactions occur in the small intestine, immune diseases are usually treated by oral capsules or fresh feces administered through the duodenum under strict anaerobic conditions, in order to ensure that active aerobic and anaerobic bacteria can be transplanted to the maximum extent and thus reshape the intestinal microecological balance[55]. Remodeling of the small intestinal flora is not appropriate for nonimmune diseases or diseases with distal intestinal malformations, but colonic delivery (enema or colonoscopy) may be an option[56].

    Whether FMT plays an important role in other diseases besides recurrent CDI needs confirmation.Donor FMT freeze-drying capsules or frozen-solution capsules have been widely used and have gained more support due to their noninvasive administration[57], and it is also convenient for the donor and recipient to make multiple trips to the hospital for transplantation on the same day[58]. Current treatments for CDI include enemas, frozen capsules or freeze-drying formulations. However, it may not be suitable for mild intestinal microecological disorders that do not comply with GMP regulations as compared to fresh feces[59].

    PREPARATION OF FMT FECAL BACTERIA LIQUID

    Due to the lack of sufficient sample size and establishment of control groups in most clinical studies[55], the conclusions are not reliable, and there is controversy about the preparation of FMT fecal bacteria solution. (1) Selection of stool dilution materials[60]. It is reported that ordinary water (98.5%)has a higher disease remission rate than normal saline (86%) as a stool dilution material, but the recurrence rate of CDI with the former increased > 2 times. Other thinners, such as milk or salt water from plantain, achieved a 94% remission rate; (2) The amount of fecal bacteria liquid transplanted.When the volume of fecal bacteria liquid transplanted is > 500 mL, the remission rate of CDI is 97%, but< 200 mL, the remission rate is only 80%. However, it is difficult to compare the above conclusions because the dilution ratio of feces may vary. Currently, according to the Amsterdam protocol, 200-300 g of donor stool is dissolved in 500 mL normal saline for use (donor stool is preferably fresh within 6 h);and (3) Feasibility of frozen feces. A case report of standardized frozen stool samples used for fecal bacteria transplantation for the treatment of CDI showed that there was no statistical difference in the efficacy of standardized frozen stool compared with fresh stool. Therefore, establishment of stool donation banks and use of standardized frozen stool made fecal bacteria transplantation more feasible in clinical practice[61]. A recent study on the treatment of CDI by oral frozen fecal bacteria capsules showed that no serious adverse reactions occurred in recurrent CDI treated by fecal bacteria transplantationviaoral frozen fecal bacteria capsules[62]. The diarrhea relief rate of single administration was 70% (14/20), while four of six patients who did not respond to treatment achieved remission after second administration, resulting in a total remission rate of 90%. This study initially demonstrated the feasibility and safety of fecal bacteria transplantationviafrozen fecal bacteria capsules[63].

    THE PROCESSING OF FMT

    Protective measures are usually taken to avoid anaerobic bacteria being killed by coming in contact with oxygen[64], but it cannot be completely avoided. Under strict anaerobic conditions, the composition of diluted or filtered microorganisms does not differ significantly before and after the entire procedure, but the activity of the preparation may have been affected[65]. Similarly, prolonged freezing at -80 °C preserved fecal components to a large extent, but whether it had an effect on fecal activity was unclear[66]. However, recent studies have shown that autologous FMT stored in glycerin at -80 °C can completely restore the intestinal lumen and mucosal microbial balance. Whether FMT regulates mild microbial disorders in these studies remains to be confirmed[67].

    DIVERSITY OF THE GUT MICROBIOME

    The diversity of intestinal flora increases with growth and development, and finally forms a complex and relatively stable microbial community at the age of 2-3 years, mainly including bacteria, fungi,viruses and protozoa[68]. There are > 1000 species of bacteria, most of which are obligate anaerobes,including Firmicutes, Bacteroides, Proteobacteria and Actinomycetes, among which Firmicutes and Bacteroides are dominant, accounting for > 90% of all intestinal bacteria[69].

    Gut microbiome composition is temporal and spatially specific. Neonatal bacteria from the birth canal colonize the intestine within a few hours after birth. The intestinal microbial composition of early vaginally delivered babies is similar to that of the mother’s vagina, while that of cesarean delivery babies is different[70]. A baby’s gut microbiota can reach the level of a healthy adult at about age 1 year.Most of the microorganisms in the human intestine colonize the colon[71], and the number is 1012cfu/mL. The microbial content of the jejunum, ileum and duodenum decreases successively, and there are 107, 104and 103cfu/mL, respectively. There are also differences in the types of microorganisms rich in each part. In addition, the composition of intestinal mucosa and fecal-associated microorganisms varies[72].

    Individuals in the same area may have different gut microbiota. The composition and diversity of intestinal microbiota may influence the therapeutic effect of donor FMT[73], or even insulin resistance.In the past few decades, with the westernization of China’s diet, intestinal microbial diversity has decreased. Preselection of donor FMT may be a feasible way to improve clinical outcomes based on the presence of a specific biological chain. Therefore, an important method to study FMT is to carefully study the baseline data of patients and the microbial composition after FMT[74]. By comparing the baseline data of the donor and the recipient and the microbial composition during a certain period of time, the number of microbes transplanted from the donor to the recipient can be calculated[75]. The most common method is fecal metagenomic sequencing, which identifies microbial species based on specific mononucleotide degeneration[76]. Sequencing techniques combined with bioinformatics analysis reveal the duration of similarity between donor and recipient strains, and how many of the transplanted microbes are likely to restore the original microbial composition[77].

    DONOR-ACCEPTOR COMBINATION

    FMT is thought to restore disturbed gut flora to a healthy state either by implanting a donor strain or by other donor-dependent traits, such as the amount of nonbacterial components[78]. However, not all donor gut microbiota are uniform, and comparison of gut microbiota from different donors suggests that microbial diversity and metabolites may be predictors of the success of FMT[79]. In some studies,donor microbiome and metabolomic characteristics may be associated with FMT treatment response.Therefore, the selection of appropriate donor feces is a key factor in the success of FMT[80]. However,few studies of FMT have considered the influence of the variation characteristics of the intestinal microbiome and metabolome of the donor on clinical efficacy[81].

    Current studies have confirmed that after FMT treatment, the intestinal flora diversity of the recipient is significantly increased and tends to be the flora characteristics of the donor[82]. Cases that respond to FMT treatment typically show higher microbial diversity. It has been confirmed that intestinal bacterial abundance in donors that respond to FMT is significantly higher than that in donors that do not respond[83].

    To date, donor selection methods in FMT studies have included the use of a single donor or the random selection of multiple donors from a group of screened eligible donors[84]. In 2019, Zhenget al[85] first proposed the concept of super donors and believed that the success of FMT depends on the donor[85]. However, the definition of super donor has not been established, and the clinical efficacy of donors before FMT treatment cannot be predictedv[86]. However, the failure of randomly selected single donors may be due to the selection of ineffective donors rather than the incorrect indication selection of FMT[87]. Therefore, an alternative approach is to expose each patient to multiple donors(multidonor transplants) to reduce the risk of receiving FMT from an invalid donor[88]. However, FMT is still in the clinical research stage. Single donors can provide clearer evidence for clinical studies, while multiple donors lead to false negatives or false positives in clinical studies, thus hindering the development of the FMT field and the development of new microbiome therapies[89].

    Studies have shown a surprising match between donor and recipient transplants and FMT[90]. The ability to secrete blood group antigens is associated with a reduction in gut microbial diversity, which in turn determines the likelihood of successful transplantation from nonsecreting blood group donors to secreting blood group receptors, which may also apply to human leukocyte antigens (HLAs)[91]. HLA haploidy is an important risk factor for autoimmune diseases such as T1D, and infants with HLA haploidy associated with an increased risk of T1D do form a unique microbiome[92]. What remains to be proven, however, is whether FMT can correct the high-risk microbiome associated with specific HLA haplotypes later in life[93]. In addition, it needs to be considered that intestinal immunoglobulinsecretion-binding bacteria and their components may contribute to the therapeutic effect of donor FMT[94].

    CONCOMITANT MEDICATION

    To facilitate colonization (also known as transplantation), the recipient’s gut is usually cleaned, most commonly by enemas, laxatives, or broad-spectrum antibiotics[95]. In patients with ulcerative colitis,antibiotic administration after FMT increases the risk of transplant failure, although there is evidence that antibiotic pretreatment improves the efficacy of FMT[96]. Previous studies have shown that antibiotics, metformin, berberine and other drugs can change the intestinal flora, thus affecting the state of the body[97]. A study of Finnish children aged 2-7 years found that macrolide use was associated with subsequent long-term changes in intestinal microbiota composition and metabolism: A decrease in Actinobacteria and an increase in Bacteroidetes and Proteobacteria, decreased biliary saline hydrolyase and increased resistance to macrolides[98]. It is associated with an increased risk of asthma and weight gain. The effect of penicillin on intestinal flora was weaker than that of macrolides[99]. In addition to antibiotics, many Chinese herbal extracts can alter the intestinal flora[100]. A study in Taiwan Chang Gyeong Hospital found that ganoderma lucidum extract can reduce the body weight of high-fat-diet mice, reduce inflammatory response and insulin resistance, reduce intestinal flora Firmicutes/Bacteroidetes ratio and endotoxin levels, maintain the integrity of the intestinal barrier and reduce endotoxemia. It has been found that both berberine and metformin can reverse the changes in intestinal flora in mice induced by high-fat diet and significantly reduce the diversity of intestinal flora.Proton pump inhibitors (PPIs) are among the top 10 drugs widely used worldwide, and studies have found that PPI use is associated with intestinal infections, particularly CDI[101]. PPI users had significantly increased intestinal flora ofEnterococcus,Streptococcus,Staphylococcusand opportunisticEscherichia coli[102]. In addition, cardiovascular drugs such as statins, antihypertensive drugs,antiplatelet aggregation drugs, as well as opioids and antidepressants can affect the composition of gut microbes[103]. As confounding factors such as gender and age have a great influence on these results,confounding factors should be minimized, and random number tables should be used to conduct random-grouping studies, because the reactions caused by these drugs may be caused by microbial disorders[104].

    CONCOMITANT LIFESTYLE AND DIET

    When a donor transplants microbes to a recipient, the difference in microbial composition between the two may be partly due to lifestyle differences between the donor and recipient[105]. If the recipient’s lifestyle does not change to that of the donor after FMT, then the effect on the recipient’s microbial makeup may disappear over time. People living in different continents and regions have their own unique dietary habits[106]. The diet of Europeans is rich in cheese, butter and other high-fat and highcalorie foods, while the diet of Africans is low in calories and high in dietary fiber[107]. Highthroughput sequencing comparing the intestinal microbiota of European children with that of rural children from Burkina Faso, a landlocked country in Western Africa, revealed significant differences between the two[108].Prevotellaand Xylos bacteria, which are associated with cellulose and xylan hydrolysis, were completely absent in the intestinal flora of European children on a high-calorie and high-fat diet, while the intestinal flora of African children on a low-calorie and high-fiber diet was rich in Bacteroidetes, especiallyPrevotellaand Xylos bacteria, while Firmicutes were relatively rare[109]. In addition, African children were found to have significantly more SCFAs in their intestines than European children had, and the abundance of Enterobacteriaceae (mainlyShigellaandE. coli) was found to be lower than that of European children[110]. These results suggest that the intestinal flora of African children has adapted to a diet rich in polysaccharides to ensure adequate energy intake from a fiber-rich diet and to reduce the incidence of intestinal inflammatory and infectious diseases[111]. The lack of dietary fiber in the diet of European children may be responsible for the loss of prevosiella and Xylos bacteria associated with cellulose and xylan hydrolysis[112]. Another study found that increased dietary fiber intake increased the diversity of the gut flora, as well asPrevotellaabundance[113].

    Numerous studies have shown that changes in diet determine microbial composition[114]. When autologous FMT is administered during a particular diet, the beneficial effects of the diet persist even if the diet is no longer continued[115]. Conversely, changes in an individual’s microbial composition also affect diet. A large number of studies have shown that dietary response to FMT may be related to changes in microbial composition[116]. Thus, FMT transplantation using a standardized diet during clinical interventions may be more effective because an important source of microbiome variation has been eliminated, but it has been overlooked in many studies[117].

    POTENTIAL MECHANISM OF ACTION

    Although the causal relationship between intestinal microbiota and disease is still unclear, it is sufficient to inspire researchers to implement strategies for disease management by regulating intestinal microbiota[118]. Dietary management, antibiotics, probiotics and other interventions can directly or indirectly enable the reconstruction of intestinal flora[119]. FMT is based on microbiota treatment, in which the isolated functional bacteria are transplanted into the patient to reconstruct intestinal flora and achieve a steady state of the gut microbes so as to attain the purpose of disease treatment[120]. The specific mechanism of FMT has not been clarified yet, and its complex mechanism cannot be replaced and explained by a single strain or single signal[121]. In 2007, the “Human Microbiome Project”, also known as the “Human second Genome Project”, became the cornerstone of human exploration and understanding of intestinal microbes[122]. With the in-depth study of intestinal flora, the causal relationship between intestinal microbes and diseases will become more clear, and the specific action mechanism of FMT will become more clear.

    FMT has made great progress in the treatment of recurrent CDI. However, due to infection and repeated use of antibiotics, the diversity of intestinal flora is low and the interactions between microorganisms are affected. Studies have shown that FMT with a healthy diversity of microbiome may increase microbial diversity levels to normal levels and enhance microbial interactions[123]. Recent studies have shown that microorganisms produced by biliary saltase may help improve the efficacy of FMT in the treatment of recurrent CDI, as the enzyme degrades taurocholic acid and effectively inhibitsC. difficile[124]. Other studies have shown that FMT treatment can cause some subsequent problems,such as the use of antibiotics to cause bacterial dysregulation, leading to non-C. difficile-dependent colitis recurrence, and thus requiring new FMT corrective treatment[125].

    Studies have shown that the most important source of fecal genes is prokaryotic viruses (phages)[126]. Phages are probably also the most overlooked in terms of FMT. Because diarrhea is partially relieved in patients with a small amount of microbial FMT during recurrent CDI, this suggests that phages may play an important role in maintaining host health by regulating gut microbiome composition and its phenotype[127]. Phages play an important role in gene expression of host bacteria and even determine their survival. Thus, FMT may function through donor phage regulation of the recipient flora. Currently, phage transplantation is done through aseptic filtration, which has the advantage of reducing bacterial infection. In addition, a large number of clinical studies are needed to show that phage transplantation has greater application value and potential in some diseases.

    The mechanism of action of FMT therapy may be realized through multiple pathways, which may vary according to the FMT condition. However, one of the important mechanisms may be altered microbial metabolite production. This may occur during transplantation or subsequently by newly colonized microorganisms. The effect of the production of large quantities of small molecules by microorganisms on the host needs to be further clarified[128]. The most significant is SCFA butyrate,produced mainly by fibrinolytic enzyme strains, which reduces intestinal permeability and provides nutrients to intestinal cells, producing epigenetic effects[129]. In addition, fibrinolytic enzyme strains has anti-inflammatory properties and can reduce the incidence of T1D in NOD mice[130]. Therefore,FMT may modulate immune activity through autoantigens. In addition, studies have shown reduced production of butyrate strains in T1D[131]. However, when T1D patients were given high concentrations of butyrate, no significant changes were detected in immune cells, and when T1D patients were given FMT, butyrate as an active regulator of protective b cells and immune cells was not detected by metabolomics[132]. As a result, the research impact of using noninvasive biomarkers for microbial metabolism has been largely underestimated[133]. This phenomenon may partly explain some of the differences between rodent and human studies. In addition, it should be made clear that interventional studies cannot completely exclude the potential mechanism of action of butyrate in T1D[134]. Therefore,it is a long and tortuous road to find meaningful microorganisms from clinical observational studies to improve clinical outcomes.

    APPLICAATION PROSPECT OF FMT IN CLINICAL RESEARCH

    FMT is a new theory and technology that has prospects in the treatment of intestinal microbiome disorders. However, the mechanism of action, ethical issues and effects of FMT are still controversial.The methodology of donor screening, the preparation and state of fecal bacteria solutions, and the approaches to transplantation are not uniform, and there are different reports on the safety and efficacy of FMT treatment[135]. In the future, more and higher-quality randomized controlled clinical trials should be carried out to address the above problems, so as to provide more adequate evidence-based medical evidence[136]. It is certain that with the deepening of scientific research, the mechanism of FMT will be gradually clarified; the intestinal microbial spectrum, microbial metabolites and their association with diseases will be more clear; and the FMT methodology will be more standardized[137]. Despite its limitations, FMT is currently one of the most important tools for studying the role of microorganisms in the pathogenesis of a range of chronic diseases. To improve the effectiveness of studies, further standardization of FMT should be carried out, such as dosage, transplantation method, and whether to use alternate pretreatment of fresh or frozen preparations[138]. In addition, accurate assessments and calculations are required to avoid type I errors in order to accurately assess efficacy. Of course, many meetings and forums are needed to reach consensus.

    CONCLUSION

    Donor FMT can restore intestinal microbial function and improve clinical outcomes. Therefore, the question in the future is whether the addition of specific strains of FMT to microbial-targeted therapies can help improve diet and drug therapy to improve human health. Therefore, in order to improve the clinical treatment of recurrent CDI, there is a need for more standardized FMT techniques. Rapid advances in untargeted molecules and bioinformatics have made it possible to analyze in detail the potential mechanisms of action of FMT. These results can identify important microorganisms and their metabolites, which may be used as probiotics, probiotics and epigenetic bacteria to enhance the therapeutic effect of FMT, or even replace FMT, for treatment of metabolic diseases.

    FOOTNOTES

    Author contributions:Zheng L, Ji YY and Duan SL reviewed the literature and prepared the manuscript, performed to the writing, revising of the manuscript; Zheng L and Wen XL contributed to design this work, and performed overall supervision; Zheng L wrote and revised the paper; all authors approved the final manuscript.

    Supported byShaanxi Province Natural Science Basic Research Program-General Project, No. 2019JM-580 and No.2021SF-314; Project of Shaanxi Administration of Traditional Chinese Medicine, No. 2019-ZZ-JC010; and Shaanxi Provincial Hospital of Traditional Chinese Medicine, No. 2018-04 and No. 2021-07.

    Conflict-of-interest statement:The authors declare that there are no conflicts of interest related to this study.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:China

    ORCID number:Lie Zheng 0000-0002-8243-3736; Yong-Yi Ji 0000-0003-2001-9916; Xin-Li Wen 0000-0001-5003-862X;Sheng-Lei Duan 0000-0002-4151-1718.

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    国产精品一区二区精品视频观看| 国产伦人伦偷精品视频| 人人妻人人澡欧美一区二区| 18禁黄网站禁片午夜丰满| 哪里可以看免费的av片| 日日摸夜夜添夜夜添小说| 人人妻人人澡欧美一区二区| 国产亚洲精品久久久久久毛片| 日韩精品中文字幕看吧| 国产日本99.免费观看| 久久久久国内视频| 国产免费av片在线观看野外av| 女人爽到高潮嗷嗷叫在线视频| 国产熟女午夜一区二区三区| 国产成人精品久久二区二区91| 琪琪午夜伦伦电影理论片6080| 国产又色又爽无遮挡免费看| 亚洲成人久久性| 777久久人妻少妇嫩草av网站| 亚洲在线自拍视频| 两个人视频免费观看高清| 久久久水蜜桃国产精品网| 日韩欧美一区视频在线观看| 一区二区三区国产精品乱码| 怎么达到女性高潮| 50天的宝宝边吃奶边哭怎么回事| 国内久久婷婷六月综合欲色啪| 女人被狂操c到高潮| 欧美日韩福利视频一区二区| av视频在线观看入口| 女生性感内裤真人,穿戴方法视频| 日韩欧美一区视频在线观看| 国产亚洲精品第一综合不卡| 好男人电影高清在线观看| 夜夜看夜夜爽夜夜摸| 亚洲一区中文字幕在线| 色综合婷婷激情| 久久久久久久久免费视频了| 国产在线精品亚洲第一网站| 国产人伦9x9x在线观看| 无人区码免费观看不卡| 成年人黄色毛片网站| 国产精品久久久久久人妻精品电影| 一夜夜www| 亚洲精品国产精品久久久不卡| 国产蜜桃级精品一区二区三区| 国产蜜桃级精品一区二区三区| 中文字幕人成人乱码亚洲影| 精品久久久久久,| 国产爱豆传媒在线观看 | 老司机福利观看| 午夜激情福利司机影院| 成年人黄色毛片网站| 午夜福利视频1000在线观看| 欧美成人一区二区免费高清观看 | 欧美日本视频| 亚洲国产欧美网| 国产亚洲精品一区二区www| 一级毛片女人18水好多| 亚洲国产中文字幕在线视频| 人妻久久中文字幕网| 国产成人一区二区三区免费视频网站| 男女视频在线观看网站免费 | 久久久精品欧美日韩精品| 久久精品影院6| 天天添夜夜摸| 欧美激情极品国产一区二区三区| 国产精品二区激情视频| 91麻豆精品激情在线观看国产| 亚洲第一青青草原| 亚洲av成人av| 在线天堂中文资源库| 久久中文看片网| 观看免费一级毛片| 嫩草影院精品99| 一个人免费在线观看的高清视频| 亚洲国产欧洲综合997久久, | 国产精品久久电影中文字幕| 亚洲免费av在线视频| 国内精品久久久久久久电影| 狂野欧美激情性xxxx| 日本三级黄在线观看| 法律面前人人平等表现在哪些方面| 国产激情久久老熟女| 国产精品永久免费网站| 午夜久久久在线观看| www.精华液| 男女那种视频在线观看| 久久 成人 亚洲| 欧美激情久久久久久爽电影| 日本黄色视频三级网站网址| 国产精品影院久久| 香蕉av资源在线| 在线天堂中文资源库| 男女之事视频高清在线观看| 午夜福利在线观看吧| 国产熟女午夜一区二区三区| 99久久国产精品久久久| 国产单亲对白刺激| 国产在线精品亚洲第一网站| 亚洲专区字幕在线| 婷婷精品国产亚洲av| 亚洲 欧美 日韩 在线 免费| 亚洲专区中文字幕在线| 国产av一区二区精品久久| 久久香蕉国产精品| 欧美日韩乱码在线| 国产精品久久久久久人妻精品电影| 国产精华一区二区三区| 国产私拍福利视频在线观看| 久久精品国产清高在天天线| 88av欧美| 国产三级黄色录像| а√天堂www在线а√下载| 90打野战视频偷拍视频| 俄罗斯特黄特色一大片| 欧美性猛交╳xxx乱大交人| 亚洲aⅴ乱码一区二区在线播放 | 99久久无色码亚洲精品果冻| 欧美性猛交黑人性爽| 人成视频在线观看免费观看| 精品欧美国产一区二区三| 三级毛片av免费| www.精华液| 99精品在免费线老司机午夜| 亚洲专区字幕在线| 日韩欧美 国产精品| 91成人精品电影| 黄色女人牲交| 极品教师在线免费播放| 免费在线观看成人毛片| 欧美中文日本在线观看视频| 在线国产一区二区在线| 国产亚洲精品综合一区在线观看 | 亚洲三区欧美一区| 男女做爰动态图高潮gif福利片| 亚洲精品久久成人aⅴ小说| 久久婷婷人人爽人人干人人爱| 成人一区二区视频在线观看| 婷婷亚洲欧美| 亚洲欧美日韩无卡精品| av在线播放免费不卡| 亚洲欧美日韩无卡精品| 别揉我奶头~嗯~啊~动态视频| 日本 欧美在线| 99精品久久久久人妻精品| 91国产中文字幕| 久久久久国产一级毛片高清牌| 91大片在线观看| 在线观看舔阴道视频| 国产精品国产高清国产av| 亚洲 欧美 日韩 在线 免费| 色在线成人网| 美女高潮到喷水免费观看| 又大又爽又粗| 99久久精品国产亚洲精品| 欧美成人免费av一区二区三区| 亚洲精品国产一区二区精华液| 久久人妻av系列| 色播在线永久视频| 又紧又爽又黄一区二区| 亚洲真实伦在线观看| 草草在线视频免费看| 国产精品自产拍在线观看55亚洲| 狠狠狠狠99中文字幕| 真人一进一出gif抽搐免费| 精品无人区乱码1区二区| 看免费av毛片| 人妻久久中文字幕网| 欧美中文综合在线视频| 色婷婷久久久亚洲欧美| 亚洲成人免费电影在线观看| 一a级毛片在线观看| 99国产综合亚洲精品| 亚洲五月婷婷丁香| 国产麻豆成人av免费视频| 成在线人永久免费视频| 91麻豆精品激情在线观看国产| 国产精品精品国产色婷婷| 十八禁人妻一区二区| 两人在一起打扑克的视频| 人人澡人人妻人| 黑人操中国人逼视频| 麻豆成人av在线观看| 亚洲国产毛片av蜜桃av| 18禁国产床啪视频网站| 夜夜爽天天搞| 免费在线观看亚洲国产| 男女那种视频在线观看| 精品国内亚洲2022精品成人| 国产黄片美女视频| 成人三级黄色视频| 久久久久久国产a免费观看| 色精品久久人妻99蜜桃| 亚洲成a人片在线一区二区| 看免费av毛片| 欧美精品亚洲一区二区| 国产精品综合久久久久久久免费| 亚洲 国产 在线| 男女下面进入的视频免费午夜 | 国内毛片毛片毛片毛片毛片| 在线观看免费午夜福利视频| 国产aⅴ精品一区二区三区波| 两性午夜刺激爽爽歪歪视频在线观看 | 国产91精品成人一区二区三区| 嫩草影院精品99| 欧美成狂野欧美在线观看| 99久久综合精品五月天人人| 久久久久免费精品人妻一区二区 | 天天躁狠狠躁夜夜躁狠狠躁| 亚洲成av片中文字幕在线观看| 午夜福利视频1000在线观看| 精品久久久久久成人av| 成人永久免费在线观看视频| 国产一区二区三区视频了| 他把我摸到了高潮在线观看| 十八禁网站免费在线| 51午夜福利影视在线观看| 中文字幕精品亚洲无线码一区 | 一二三四在线观看免费中文在| 身体一侧抽搐| 一a级毛片在线观看| 亚洲,欧美精品.| 久久久久久久精品吃奶| aaaaa片日本免费| 亚洲欧美日韩高清在线视频| 老司机在亚洲福利影院| 大型黄色视频在线免费观看| 欧美黄色片欧美黄色片| 亚洲国产精品成人综合色| 国产视频内射| 国产av一区在线观看免费| 一本大道久久a久久精品| 每晚都被弄得嗷嗷叫到高潮| 他把我摸到了高潮在线观看| 51午夜福利影视在线观看| av片东京热男人的天堂| 亚洲av中文字字幕乱码综合 | 国产伦人伦偷精品视频| 两人在一起打扑克的视频| 黄片播放在线免费| 成年版毛片免费区| 久久精品夜夜夜夜夜久久蜜豆 | 18禁观看日本| 久久狼人影院| 久久中文字幕一级| 日本一区二区免费在线视频| 国产精品一区二区免费欧美| 女性被躁到高潮视频| 国产精品久久久av美女十八| 亚洲精品国产精品久久久不卡| 51午夜福利影视在线观看| 日韩一卡2卡3卡4卡2021年| 黄片播放在线免费| 一区二区三区激情视频| 两个人免费观看高清视频| 久久人妻福利社区极品人妻图片| 亚洲一卡2卡3卡4卡5卡精品中文| 国产亚洲欧美精品永久| 欧美日韩瑟瑟在线播放| 日韩欧美国产一区二区入口| 18禁国产床啪视频网站| 亚洲黑人精品在线| 法律面前人人平等表现在哪些方面| 国产精品国产高清国产av| 村上凉子中文字幕在线| 日韩视频一区二区在线观看| 国产精品美女特级片免费视频播放器 | 亚洲国产日韩欧美精品在线观看 | 午夜福利欧美成人| 精品久久久久久久毛片微露脸| 99精品久久久久人妻精品| 最新美女视频免费是黄的| 久久精品91蜜桃| 日本五十路高清| 天堂动漫精品| 一区二区三区精品91| 欧洲精品卡2卡3卡4卡5卡区| 熟妇人妻久久中文字幕3abv| 村上凉子中文字幕在线| 亚洲狠狠婷婷综合久久图片| 午夜福利在线观看吧| 亚洲第一电影网av| 日韩欧美免费精品| 黄频高清免费视频| 日本一区二区免费在线视频| 最近最新中文字幕大全电影3 | 999精品在线视频| 中文字幕人妻丝袜一区二区| 精品久久久久久久末码| 狂野欧美激情性xxxx| 搞女人的毛片| 村上凉子中文字幕在线| 欧美日韩亚洲综合一区二区三区_| 黄色片一级片一级黄色片| 日日夜夜操网爽| 亚洲人成网站在线播放欧美日韩| 国产主播在线观看一区二区| 久久亚洲真实| 校园春色视频在线观看| 少妇熟女aⅴ在线视频| 国产爱豆传媒在线观看 | 91成人精品电影| 久久中文字幕人妻熟女| 国产单亲对白刺激| 亚洲精品国产区一区二| 黑丝袜美女国产一区| 久99久视频精品免费| 精品国产国语对白av| 一级a爱片免费观看的视频| 青草久久国产| 亚洲国产日韩欧美精品在线观看 | 十八禁网站免费在线| 国内精品久久久久久久电影| 无限看片的www在线观看| 免费av毛片视频| 国产熟女午夜一区二区三区| 一区二区三区国产精品乱码| 97人妻精品一区二区三区麻豆 | 色综合欧美亚洲国产小说| 色婷婷久久久亚洲欧美| 国产又爽黄色视频| 亚洲精华国产精华精| 久久久久久久久免费视频了| 最好的美女福利视频网| 欧美zozozo另类| 久久人妻av系列| 日韩精品青青久久久久久| 日韩欧美免费精品| 正在播放国产对白刺激| 一区二区三区高清视频在线| 国产亚洲精品久久久久5区| 午夜久久久久精精品| 男人舔女人的私密视频| 俄罗斯特黄特色一大片| 日韩欧美在线二视频| 久久久久久免费高清国产稀缺| 亚洲中文av在线| 亚洲欧美激情综合另类| 一级黄色大片毛片| 日韩视频一区二区在线观看| 成人亚洲精品av一区二区| 国产视频一区二区在线看| 久久久久久大精品| 久久草成人影院| 黄色成人免费大全| 国产av不卡久久| 国内精品久久久久久久电影| 色老头精品视频在线观看| 2021天堂中文幕一二区在线观 | 久热爱精品视频在线9| 久久久久久久久久黄片| 国产区一区二久久| 日本成人三级电影网站| 国产精品爽爽va在线观看网站 | 国产精品乱码一区二三区的特点| 亚洲成人国产一区在线观看| 久99久视频精品免费| 国产精品乱码一区二三区的特点| 男女床上黄色一级片免费看| 欧美中文日本在线观看视频| 日韩中文字幕欧美一区二区| 听说在线观看完整版免费高清| 久久国产精品人妻蜜桃| 日韩精品青青久久久久久| av超薄肉色丝袜交足视频| 窝窝影院91人妻| 国产精品久久久人人做人人爽| 日韩有码中文字幕| 国产精品99久久99久久久不卡| 欧美性猛交黑人性爽| 美女扒开内裤让男人捅视频| 大型黄色视频在线免费观看| 18美女黄网站色大片免费观看| 色播在线永久视频| 国产免费av片在线观看野外av| 国产视频内射| 国产精品综合久久久久久久免费| 中亚洲国语对白在线视频| 午夜日韩欧美国产| 国产精品久久久久久精品电影 | 天天躁狠狠躁夜夜躁狠狠躁| 欧美色视频一区免费| 亚洲熟女毛片儿| 男女视频在线观看网站免费 | 侵犯人妻中文字幕一二三四区| 国产精品精品国产色婷婷| 男女那种视频在线观看| 国产野战对白在线观看| 日韩亚洲欧美综合| 伦精品一区二区三区| 国产精品人妻久久久影院| 国产真实乱freesex| 亚洲精品久久国产高清桃花| 久久国内精品自在自线图片| 一卡2卡三卡四卡精品乱码亚洲| 国产精品1区2区在线观看.| 亚洲熟妇熟女久久| 欧洲精品卡2卡3卡4卡5卡区| 国产爱豆传媒在线观看| 亚洲五月天丁香| 午夜视频国产福利| 精品久久久久久久久亚洲| 麻豆国产av国片精品| 婷婷精品国产亚洲av| 色视频www国产| 又黄又爽又免费观看的视频| 国产高清视频在线观看网站| 亚洲人与动物交配视频| 小说图片视频综合网站| 激情 狠狠 欧美| 大又大粗又爽又黄少妇毛片口| 3wmmmm亚洲av在线观看| 毛片女人毛片| 成年版毛片免费区| 99九九线精品视频在线观看视频| 久久精品国产亚洲av天美| 男人舔奶头视频| 69人妻影院| 赤兔流量卡办理| 深夜精品福利| 成年av动漫网址| 大型黄色视频在线免费观看| 亚洲五月天丁香| 人妻制服诱惑在线中文字幕| 一级毛片电影观看 | 婷婷精品国产亚洲av在线| 亚洲最大成人手机在线| 国产老妇女一区| 一级毛片久久久久久久久女| a级一级毛片免费在线观看| 国产男人的电影天堂91| 日本三级黄在线观看| 亚洲欧美日韩无卡精品| 简卡轻食公司| 九九在线视频观看精品| 天美传媒精品一区二区| 欧美日本视频| 国产av不卡久久| 天堂网av新在线| 日韩三级伦理在线观看| 亚洲av电影不卡..在线观看| 亚洲美女黄片视频| 99热这里只有是精品在线观看| 国产视频内射| 国产单亲对白刺激| 大型黄色视频在线免费观看| 老司机影院成人| 亚洲专区国产一区二区| 成人漫画全彩无遮挡| 99久久精品一区二区三区| 亚洲av免费在线观看| 99久国产av精品| 午夜影院日韩av| 欧美xxxx性猛交bbbb| 精品熟女少妇av免费看| 亚洲婷婷狠狠爱综合网| 黄色一级大片看看| 中国国产av一级| 18+在线观看网站| 中文字幕熟女人妻在线| 国产精品野战在线观看| 国产一区亚洲一区在线观看| 亚洲精品乱码久久久v下载方式| 国产真实伦视频高清在线观看| 免费在线观看成人毛片| 大型黄色视频在线免费观看| 乱系列少妇在线播放| 国产女主播在线喷水免费视频网站 | 黄色视频,在线免费观看| 美女被艹到高潮喷水动态| 日韩欧美一区二区三区在线观看| 国产美女午夜福利| 免费无遮挡裸体视频| 波多野结衣高清作品| 熟女人妻精品中文字幕| 国产色婷婷99| 精品一区二区三区人妻视频| 18禁黄网站禁片免费观看直播| a级毛片免费高清观看在线播放| 久久久久久久久久久丰满| 久久精品久久久久久噜噜老黄 | 久久精品夜夜夜夜夜久久蜜豆| 最新在线观看一区二区三区| 人人妻人人澡欧美一区二区| 午夜激情福利司机影院| ponron亚洲| 可以在线观看的亚洲视频| 天天躁夜夜躁狠狠久久av| 最近在线观看免费完整版| 成年女人看的毛片在线观看| 欧美xxxx黑人xx丫x性爽| 国语自产精品视频在线第100页| 日韩av在线大香蕉| 搞女人的毛片| а√天堂www在线а√下载| 91狼人影院| 欧美性感艳星| 中文字幕av在线有码专区| 国产一区二区在线av高清观看| 国产在线精品亚洲第一网站| 色吧在线观看| 最近最新中文字幕大全电影3| 久久婷婷人人爽人人干人人爱| 国产大屁股一区二区在线视频| 亚洲综合色惰| 久久久久久久久久久丰满| 99久久中文字幕三级久久日本| 老师上课跳d突然被开到最大视频| 国产精品一及| 国产又黄又爽又无遮挡在线| 91麻豆精品激情在线观看国产| 亚洲av成人精品一区久久| 亚洲熟妇中文字幕五十中出| 丝袜喷水一区| 国产精品一及| 黄色欧美视频在线观看| 亚洲18禁久久av| 亚洲av成人精品一区久久| 黑人高潮一二区| 天堂影院成人在线观看| 国产精品国产三级国产av玫瑰| 又黄又爽又刺激的免费视频.| 高清日韩中文字幕在线| 欧美国产日韩亚洲一区| 日韩精品有码人妻一区| 亚洲图色成人| 欧美bdsm另类| 99热这里只有是精品在线观看| 欧美又色又爽又黄视频| 午夜激情福利司机影院| 欧美又色又爽又黄视频| 日本撒尿小便嘘嘘汇集6| 亚洲真实伦在线观看| 夜夜夜夜夜久久久久| 国产一区二区三区av在线 | 又爽又黄无遮挡网站| 亚洲精品日韩av片在线观看| 国产精品久久久久久久久免| 自拍偷自拍亚洲精品老妇| 一级黄片播放器| 村上凉子中文字幕在线| 欧美丝袜亚洲另类| 神马国产精品三级电影在线观看| 一级黄片播放器| 国产真实伦视频高清在线观看| 又爽又黄无遮挡网站| 久久国产乱子免费精品| 蜜桃久久精品国产亚洲av| 男女做爰动态图高潮gif福利片| 亚洲不卡免费看| 亚洲精品色激情综合| 天堂网av新在线| 色哟哟·www| 久久久欧美国产精品| 超碰av人人做人人爽久久| 成年版毛片免费区| 久久天躁狠狠躁夜夜2o2o| 国产极品精品免费视频能看的| 老司机影院成人| 精品人妻偷拍中文字幕| 99在线视频只有这里精品首页| 国产乱人视频| 亚洲成a人片在线一区二区| 精华霜和精华液先用哪个| 日本三级黄在线观看| 热99在线观看视频| av黄色大香蕉| 十八禁网站免费在线| 成人精品一区二区免费| 国产精品爽爽va在线观看网站| 国产亚洲精品综合一区在线观看| 乱人视频在线观看| 国产精品亚洲美女久久久| 亚洲av熟女| 人人妻人人澡人人爽人人夜夜 | 日本爱情动作片www.在线观看 | 久久6这里有精品| 三级经典国产精品| 亚洲四区av| 日韩人妻高清精品专区| 又爽又黄无遮挡网站| 久久国产乱子免费精品| 国产久久久一区二区三区| 国产成年人精品一区二区| 99久久精品一区二区三区| 国产精品女同一区二区软件| 日韩精品中文字幕看吧| 欧美成人一区二区免费高清观看| 成人特级黄色片久久久久久久| 99在线视频只有这里精品首页| 亚洲熟妇熟女久久| 久久久久久久久中文| 在线观看美女被高潮喷水网站| 亚洲av二区三区四区| 亚洲精品国产av成人精品 | 男人和女人高潮做爰伦理| 97碰自拍视频| 女的被弄到高潮叫床怎么办| 香蕉av资源在线| 日韩一区二区视频免费看| 国产精品精品国产色婷婷| 精品福利观看| 好男人在线观看高清免费视频| 日日啪夜夜撸| 99久国产av精品| 免费不卡的大黄色大毛片视频在线观看 | 久久草成人影院| avwww免费| 久久久a久久爽久久v久久| 国产成人福利小说| 国产伦在线观看视频一区| 少妇猛男粗大的猛烈进出视频 | 真人做人爱边吃奶动态| 成人午夜高清在线视频|